Identification of differential key biomarkers in the synovial tissue between rheumatoid arthritis and osteoarthritis using bioinformatics analysis
- PMID: 34224029
- DOI: 10.1007/s10067-021-05825-1
Identification of differential key biomarkers in the synovial tissue between rheumatoid arthritis and osteoarthritis using bioinformatics analysis
Abstract
Introduction/objectives: Rheumatoid arthritis (RA) and osteoarthritis (OA) are two common joint diseases with similar clinical manifestations. Our study aimed to identify differential gene biomarkers in the synovial tissue between RA and OA using bioinformatics analysis and validation.
Method: GSE36700, GSE1919, GSE12021, GSE55235, GSE55584, and GSE55457 datasets were downloaded from the Gene Expression Omnibus database. A total of 57 RA samples and 46 OA samples were included. The differentially expressed genes (DEGs) were identified. The Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were also performed. Protein-protein interaction (PPI) network of DEGs and the hub genes were constructed and visualized via Search Tool for the Retrieval of Interacting Genes/Proteins, Cytoscape, and R. Selected hub genes were validated via reverse transcription-polymerase chain reaction.
Results: A total of 41 DEGs were identified. GO functional enrichment analysis showed that DEGs were enriched in immune response, signal transduction, regulation of immune response for biological process, in plasma membrane and extracellular region for cell component, and antigen binding and serine-type endopeptidase activity for molecular function. KEGG pathway analysis showed that DEGs were enriched in cytokine-cytokine receptor interaction and chemokine signaling pathway. PPI network analysis established 70 nodes and 120 edges and 15 hub genes were identified. The expression of CXCL13, CXCL10, and ADIPOQ was statistically different between RA and OA synovial tissue.
Conclusion: Differential expression of CXCL13, CXCL10, and ADIPOQ between RA and OA synovial tissue may provide new insights for understanding the RA development and difference between RA and OA. Key Points • Bioinformatics analysis was used to identify the differentially expressed genes in the synovial tissue between rheumatoid arthritis and osteoarthritis. • CXCL13, CXCL10, and ADIPOQ might provide new insight for understanding the differences between RA and OA.
Keywords: Bioinformatics analysis; Osteoarthritis; Rheumatoid arthritis; Synovial tissue.
© 2021. International League of Associations for Rheumatology (ILAR).
Similar articles
-
Identification of potential biomarkers for differential diagnosis between rheumatoid arthritis and osteoarthritis via integrative genome‑wide gene expression profiling analysis.Mol Med Rep. 2019 Jan;19(1):30-40. doi: 10.3892/mmr.2018.9677. Epub 2018 Nov 20. Mol Med Rep. 2019. PMID: 30483789 Free PMC article.
-
Identification of Disease-Specific Hub Biomarkers and Immune Infiltration in Osteoarthritis and Rheumatoid Arthritis Synovial Tissues by Bioinformatics Analysis.Dis Markers. 2021 May 17;2021:9911184. doi: 10.1155/2021/9911184. eCollection 2021. Dis Markers. 2021. PMID: 34113405 Free PMC article.
-
Identification and validation of hub genes of synovial tissue for patients with osteoarthritis and rheumatoid arthritis.Hereditas. 2021 Sep 28;158(1):37. doi: 10.1186/s41065-021-00201-0. Hereditas. 2021. PMID: 34583778 Free PMC article.
-
Single-cell transcriptomic analysis to identify endomembrane regulation of metalloproteins and motor proteins in autoimmunity.Adv Protein Chem Struct Biol. 2024;141:299-329. doi: 10.1016/bs.apcsb.2024.03.007. Epub 2024 Apr 10. Adv Protein Chem Struct Biol. 2024. PMID: 38960478 Review.
-
RNAseq of Osteoarthritic Synovial Tissues: Systematic Literary Review.Front Aging. 2022 May 25;3:836791. doi: 10.3389/fragi.2022.836791. eCollection 2022. Front Aging. 2022. PMID: 35821799 Free PMC article.
Cited by
-
Bioinformatics Analysis Identified the Hub Genes, mRNA-miRNA-lncRNA Axis, and Signaling Pathways Involved in Rheumatoid Arthritis Pathogenesis.Int J Gen Med. 2022 Apr 8;15:3879-3893. doi: 10.2147/IJGM.S353487. eCollection 2022. Int J Gen Med. 2022. PMID: 35422654 Free PMC article.
-
Structural and Pharmacological Network Focused on MiRNAs Involved in Rheumatoid Arthritis: A Systematic Review.Curr Mol Med. 2024;24(5):599-609. doi: 10.2174/1566524023666230423144114. Curr Mol Med. 2024. PMID: 37185324
-
Identification of immune microenvironment subtypes and clinical risk biomarkers for osteoarthritis based on a machine learning model.Front Mol Biosci. 2024 Oct 17;11:1376793. doi: 10.3389/fmolb.2024.1376793. eCollection 2024. Front Mol Biosci. 2024. PMID: 39484639 Free PMC article.
-
Identification of SLAMF1 as an immune-related key gene associated with rheumatoid arthritis and verified in mice collagen-induced arthritis model.Front Immunol. 2022 Aug 30;13:961129. doi: 10.3389/fimmu.2022.961129. eCollection 2022. Front Immunol. 2022. PMID: 36110846 Free PMC article.
-
Identification of the candidate genes of diagnosing rheumatoid arthritis using the single-cell sequencing technology and T cell subclusters analysis of patients with rheumatoid arthritis.Arch Rheumatol. 2022 Jul 29;38(1):109-118. doi: 10.46497/ArchRheumatol.2022.9573. eCollection 2023 Mar. Arch Rheumatol. 2022. PMID: 37235118 Free PMC article.
References
-
- McInnes IB (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219. https://doi.org/10.1056/NEJMra1004965 - DOI - PubMed
-
- Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. 376:1094–1108. https://doi.org/10.1016/S0140-6736(10)60826-4
-
- Smolen JS, Aletaha D, Barton A et al (2018) Rheumatoid arthritis. Nat Rev Dis Primer 4:18001. https://doi.org/10.1038/nrdp.2018.1 - DOI
-
- Buckwalter J, Martin J (2006) Osteoarthritis. Adv Drug Deliv Rev 58:150–167. https://doi.org/10.1016/j.addr.2006.01.006 - DOI - PubMed
-
- Felson DT (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635. https://doi.org/10.7326/0003-4819-133-8-200010170-00016 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous